Affimed N.V. - 54 Year Dividend History | AFMD
Historical dividend payout and yield for Affimed N.V. (AFMD) since 1971. The current TTM dividend payout for Affimed N.V. (AFMD) as of February 21, 2025 is $0.00. The current dividend yield for Affimed N.V. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.017B |
$0.009B |
|
Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
